What You Should Know:
- DreaMed Diabetes, the developer of personalized,
AI-based diabetes management solutions, will participate in a clinical study,
led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual
treatment for diabetes patients. The research is funded by a $5 million grant
from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management
Read More
Type 2 Diabetes - Chronic Disease Management | News, Analysis, Insights - HIT Consultant
Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform
What You Should Know:
- Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients.
- To date, the company has treated more than a million patients
online for a variety of medical conditions ranging from erectile dysfunction to sinus infections
to depression and anxiety for roughly $25/visit (less than a typical co-pay).
Lemonaid Health,
a convenient,
Read More
COVID-19 Chronic Condition Patient Population Report
What You Should Know:
Wellframe report finds patients want access to virtual
solutions to help manage their chronic conditions amidst the COVID-19 pandemic.
The survey indicates that the COVID-19 pandemic has had a
significant effect on the chronic condition population by delaying access to
care and exacerbating mental health challenges.
Wellframe, a
provider of Digital Health Management solutions, announced the findings of its COVID-19
Chronic Condition Patient Population Report
Read More
Welldoc Awarded 8th FDA Clearance for Bluestar Medical Device for Diabetes
What You Should Know:
Marks 8th FDA clearance for BlueStar, the only
reimbursable software as a medical device for diabetes that integrates with all
of a patient's existing devices.
Welldoc, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, announced today that the U.S. Food and Drug Administration (FDA) has cleared an additional feature for the digital health product BlueStar Rx which supports individuals using long-acting
Read More
Non-Invasive Technology for Measuring & Monitoring Liver Fat
Scott Howell, D.O., MPH&TM, CPE, Advisor to Echosens
As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity.
Diabetes is one of the leading causes of disability and death in the United States. One in 10
Read More
Omada Health Acquires Telehealth Physical Therapy Company Physera
What You Should Know
Tele-physical therapy company Physera announced that
they are joining Omada Health, a digital health company that offers
programs for chronic disease prevention and management, and mental health
support.
Through the deal, Omada adds Physera’s musculoskeletal
solution to its suite of digital care programs for the prevention and self-management
of diabetes, hypertension, and mental health.
Physera recently launched a
Read More
Why Now’s the Time to Use Connected Health Devices for Diabetes Prevention
Charlotte Puechmaille, Director of Strategy, New Health Businesses at Withings
It’s no secret that chronic disease remains the leading cause of death worldwide, taking up 90 percent of healthcare spending in the United States. For the last several years, there has been a rise in discussions and research around the promise of connected health devices helping manage and prevent chronic conditions as well as healthcare spending. However, today a number of factors are coming together to make that
Read More
One Drop Acquires Sano’s Continuous Glucose Sensing Platform
What You Should Know:
- One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform.
- One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
One Drop, a New York
City-based provider of digital care solutions for people
Read More
6 Benefits of Telemedicine in Managing the Diabetes Epidemic
Dean Smith, MD, Chief Medical Officer for GlobalMed
The American Diabetes Association reveals that 9.4% of the American population has diabetes, and with numbers that high nearly all Americans have a friend or family member with the disease. However, many Americans are not aware that telehealth can enable diabetic patients to manage their condition—treatment that would have otherwise been difficult to come by for rural patients with limited access to care.
With such a high prevalence among
Read More
Lilly to Integrate Dexcom CGMs into Personalized Diabetes Management System
- Eli Lilly has announced a global commercialization agreement to integrate Dexcom’s continuous glucose monitoring (CGM) devices into Lilly’s personalized diabetes management system. - The personalized diabetes management system, currently in development to advance the treatment of diabetes, will integrate connected insulin delivery devices, software and analysis to equip people with diabetes and their healthcare providers with personalized information and guidance to help them better manage
Read More
